Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Clene
AddedFeb 20, 2024
UpdatedJul 4, 2026
Clene

Clene

Public

Clene Inc., a Utah-based clinical-stage pharmaceutical company, develops novel nanotech therapeutics and dietary supplements for various diseases.

HQ
Salt Lake City, UT, US
Founded
2023
Overview
Compare
Employees
Website

Clene Inc. is a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases. Based in Utah, the company develops novel clean-surfaced nanotechnology (CSN) therapeutics targeting cellular energy impairments common to many neurological conditions. Their lead drug candidate, CNM-Au8, is being studied in various clinical trials for conditions such as amyotrophic lateral sclerosis (ALS).

The company's innovative approach aims to restore and protect neuronal health and function through its nanotherapeutic platform. Clene's pipeline includes catalytic nanocrystals designed to address energy impairments at the cellular level, potentially offering new treatment options for patients with neurodegenerative diseases. The company's commitment to advancing these therapies positions it at the forefront of neurological research and development.

Clene - Similar Companies

EnClear Therapies logo

EnClear Therapies

CuraSen Therapeutics logo

CuraSen Therapeutics

curasen.com

NanoPharmaceuticals logo

NanoPharmaceuticals

Nano Genesis Labs logo

Nano Genesis Labs

Cleave Therapeutics logo

Cleave Therapeutics

NeuroHope Therapeutics logo

NeuroHope Therapeutics

Neuraly logo

Neuraly

neuralymed.com

Neuronascent logo

Neuronascent

neuronascent.com

Nano Cures logo

Nano Cures

nanocures.com

Escape Bio logo

Escape Bio

escapebio.com

Advanced NanoTherapies logo

Advanced NanoTherapies

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

Nomax Therapeutics logo

Nomax Therapeutics

2C Tech logo

2C Tech

It's Nanoed logo

It's Nanoed

Clene - Quick Facts

Who are Clene's competitors?

Companies similar to Clene include EnClear Therapies, CuraSen Therapeutics, NanoPharmaceuticals and Nano Genesis Labs.

When was Clene founded?

Clene was founded in 2023.

Where is Clene's headquarters located?

Clene's headquarters is located in Salt Lake City, UT, US.

How many employees does Clene have?

Clene has 75 employees as of Feb 6, 2024.

Clene - Classification

Ownership
  • Public
Technology
  • Nanotechnology
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Supplements
  • Therapeutics
Tags
  • Biotech
  • Healthtech
Unique IDs
  • secCik: 0001822791
  • ticker: CLNN
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research